Advertisements
Feeds:
Posts
Comments

Search Results for 'CRISPR'

Top 10 CRISPR Podcasts Every Scientist (& Non-Scientist) by Synthego.com

Posted in CRISPR/Cas9 & Gene Editing, LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on March 9, 2019| Leave a Comment »


Top 10 CRISPR Podcasts Every Scientist (& Non-Scientist) by Synthego.com Reporter: Aviva Lev-Ari, PhD, RN     On 3/12/2015 – Dr. Williams posted Podcast Review: Quiet Innovation Podcast on Obtaining $ for Your Startup Reporter: Stephen J. Williams, Ph.D. https://pharmaceuticalintelligence.com/2015/03/12/podcast-review-quiet-innovation-podcast-on-obtaining-for-your-startup/   On 1/25/2016 – I posted Launching LPBI’s, Fourth Line of Business (D): FIVE Podcast – Audio […]

Read Full Post »

Opportunities and Ethics of Editing Genomes: A CRISPR-Inspired Conversation, Prof. Jennifer Doudna’s Lecture at Stanford University, JANUARY 24, 2019 – 7:00PM TO 8:30PM, CEMEX AUDITORIUM, GRADUATE SCHOOL OF BUSINESS

Posted in CRISPR applied to Human Germ Line, CRISPR/Cas9 & Gene Editing, tagged on January 16, 2019| Leave a Comment »


Opportunities and Ethics of Editing Genomes: A CRISPR-Inspired Conversation, Prof. Jennifer Doudna’s Lecture at Stanford University, JANUARY 24, 2019 – 7:00PM TO 8:30PM, CEMEX AUDITORIUM, GRADUATE SCHOOL OF BUSINESS Reporter: Aviva Lev-Ari, PhD, RN   Opportunities and Ethics of Editing Genomes: A CRISPR-Inspired Conversation JANUARY 24, 2019 – 7:00PM TO 8:30PM EVENT SERIES: ARROW LECTURES EVENT SPONSOR: CENTER […]

Read Full Post »

Will the Supreme Court accept a UC Berkeley Appeal of the Sep. 10th, US Court of Appeals for the Federal Circuit decision to uphold the patent filed by the Broad Institute on CRISPR/Cas9 gene editing?

Posted in CRISPR/Cas9 & Gene Editing, Disputes and Settlements, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Patent Law in Biotech on September 14, 2018| 2 Comments »


Will the Supreme Court accept a UC Berkeley Appeal of the Sep. 10th, US Court of Appeals for the Federal Circuit decision to uphold the patent filed by the Broad Institute on CRISPR/Cas9 gene editing? Reporter: Aviva Lev-Ari, PhD, RN   On 2018, Sep. 10th, the US Court of Appeals for the Federal Circuit agreed to uphold the patent filed […]

Read Full Post »

Sickle Cell and Beta Thalassemia chosen for first human trial of the gene editing technology, CRISPR by sponsoring companies CRISPR Therapeutics and Vertex Pharmaceuticals, trial at a single site in Germany, 

Posted in CRISPR/Cas9 & Gene Editing, Gene Therapy & Gene Editing Development, Genome Biology on September 4, 2018| Leave a Comment »


Sickle Cell and Beta Thalassemia chosen for first human trial of the gene editing technology, CRISPR by sponsoring companies CRISPR Therapeutics and Vertex Pharmaceuticals, trial at a single site in Germany,   Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 3/09/2019 CRISPR Therapeutics share up on announcement of first dosing in the joint Vertex sponsored trial for […]

Read Full Post »

Unwanted DNA deletions by CRISPR gene editing technology

Posted in Biological Engineering, Biological Networks, Gene Regulation and Evolution, Cancer and Current Therapeutics, Cancer Genomics, Cancer Prevention: Research & Programs, Cell Biology, Clinical Genomics, DNA repair, Gene Regulation, Gene Regulation and Evolution, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Genetics & Pharmaceutical, Genome Biology, Genomic Endocrinology, Genomic Testing: Methodology for Diagnosis, Genomics Pharmacy, Molecular Genetics & Pharmaceutical, mRNA Therapeutics, Personalized and Precision Medicine & Genomic Research, Uncategorized, tagged , , , , on July 22, 2018| Leave a Comment »


Reporter and Curator: Dr. Sudipta Saha, Ph.D.   Researchers have embraced CRISPR gene-editing as a method for altering genomes, but some have reported that unwanted DNA changes may slip by undetected. The tool can cause large DNA deletions and rearrangements near its target site on the genome. Such alterations can confuse the interpretation of experimental […]

Read Full Post »

New CRISPR Approach Transforms Skin Cells into Pluripotent Stem Cells

Posted in Cell Processing System in Cell Therapy Process Development, Stem Cells for Regenerative Medicine, Uncategorized, tagged , , , on July 9, 2018| Leave a Comment »


New CRISPR Approach Transforms Skin Cells into Pluripotent Stem Cells Reporter: Irina Robu, PhD Dr. Timo Otonkoski, University of Helsinki and Dr.Juha Kere, King’s College London succeeded on reprograming skin cells into pluripotent stem cells by activating cell’s own genes using gene editing technology, CRISPR-Cas9-based gene activation (CRISPRa) that can be used to activate genes. […]

Read Full Post »

On June 12, 2018 – Berkeley was granted a patent on using CRISPR/Cas9 to edit single-stranded RNA. On June 19, 2018 – Berkeley was granted a second patent, covering the use of CRISPR-Cas9 gene editing with formats that will be particularly useful in developing human therapeutics and improvements in food security.

Posted in CRISPR/Cas9 & Gene Editing, Disputes and Settlements, Intellectual Property, Intellectual Property, Innovations, Commercialization, Investment in technological breakthrough, Patent Law in Biotech on June 21, 2018| Leave a Comment »


On June 12, 2018 – Berkeley was granted a patent on using CRISPR/Cas9 to edit single-stranded RNA. On June 19, 2018 – Berkeley was granted a second patent, covering the use of CRISPR-Cas9 gene editing with formats that will be particularly useful in developing human therapeutics and improvements in food security. Reporter and Curator: Aviva Lev-Ari, PhD, RN […]

Read Full Post »

Cancer threat in CRISPR/Cas9 method

Posted in Apoptosis, Apoptosis, Cancer - General, Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Genomics, Cancer Prevention: Research & Programs, Cancer Screening, Cancer-Immune Interactions, Cell Biology, Cell death pathways, Cell Processing System in Cell Therapy Process Development, Clinical Genomics, DNA repair, Efficacy of Anti-Tumor T Cells, Gene Regulation, Gene Therapy & Gene Editing Development, Genetics & Innovations in Treatment, Human Antibody Response, Transformative Technologies in Healthcare, Translational Research, tagged , , , , on June 17, 2018| Leave a Comment »


Reporter and Curator: Dr. Sudipta Saha, Ph.D.   The CRISPR-Cas9 system has proven to be a powerful tool for genome editing allowing for the precise modification of specific DNA sequences within a cell. Many efforts are currently underway to use the CRISPR-Cas9 system for the therapeutic correction of human genetic diseases. CRISPR/Cas9 has revolutionized our […]

Read Full Post »

CRISPR on TED Ideas worth spreading – Ellen Jorgensen

Posted in CRISPR/Cas9 & Gene Editing on February 8, 2018| Leave a Comment »


CRISPR on TED Ideas worth spreading – Ellen Jorgensen Reporter: Aviva Lev-Ari, PhD, RN On same webpage see other CRISPR Talk on TED on the right hand side of the webpage   SOURCE

Read Full Post »

CRISPR snips a strand of DNA – Visualization of the Process

Posted in CRISPR/Cas9 & Gene Editing on February 4, 2018| Leave a Comment »


CRISPR snips a strand of DNA – Visualization of the Process Reporter: Aviva Lev-Ari, PhD, RN   Watch what it actually looks like when CRISPR snips a strand of DNA Posted Jan 31, 2018 by Devin Coldewey WATCH VIDEO Molecular animations are an essential way to demystify and explain complex biological systems. Through the use of stunning imagery and attention to detail, […]

Read Full Post »

Next »